Sheaff Brock Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BC
Sheaff Brock Investment Advisors's XBI Position: Q4 2021 in Review
Sheaff Brock Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 1,649 shares — an estimated $207K sold.
Sheaff Brock Investment Advisors first reported a position in XBI in Q4 2015 and held it in 17 quarters. The position peaked at $335K in Q3 2018. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.
- Sheaff Brock Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
- Sheaff Brock Investment Advisors sold 1,649 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $207K.
- Sheaff Brock Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 17 quarters.
- Sheaff Brock Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $335K in Q3 2018.
- 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.
Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.